Abstract:Advancing age is a major risk factor for respiratory viral infections. The infections are often prolonged and difficult to resolve resulting hospitalizations and mortality. The recent COVID-19 pandemic has highlighted this as elderly subjects have emerged as vulnerable populations that display increased susceptibility and severity to SARS-CoV-2. There is an urgent need to identify the probable mechanisms underlying this to protect against future outbreaks of such nature. Innate immunity is the first line of defense against viruses and its decline impacts downstream immune responses. This is because dendritic cells (DCs) and macrophages are key cellular elements of the innate immune system that can sense and respond to viruses by producing inflammatory mediators and priming CD4 and CD8 T-cell responses.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the changes in the human innate immune response to the SARS - CoV - 2 virus as people age. Specifically, the study aims to understand why the immune response of the elderly to SARS - CoV - 2 is weakened and how this change makes the elderly more likely to develop severe COVID - 19 diseases. By comparing the responses of peripheral blood mononuclear cells (PBMCs) from individuals of different age groups (young, middle - aged, and elderly) to SARS - CoV - 2, researchers hope to reveal the specific mechanisms of age - related decline in immune function, especially the functional changes of dendritic cells (DCs) and monocytes. These findings are helpful for the development of new treatment strategies for the elderly population, not only for COVID - 19, but also for other respiratory infections. ### Research Background As people age, their ability to fight against respiratory virus infections decreases significantly, which leads to a longer course of disease, higher hospitalization rates, and mortality rates. Especially during the COVID - 19 epidemic, the elderly have been proven to be a high - risk group, showing higher susceptibility and disease severity. Therefore, there is an urgent need to identify potential mechanisms to protect against future outbreaks of similar epidemics. The innate immune system is the first line of defense against viruses, and its decline in function will affect downstream immune responses. Dendritic cells (DCs) and macrophages are key cellular components of the innate immune system, which can sense and respond to viruses, produce inflammatory mediators, and initiate CD4 and CD8 T - cell responses. ### Research Results Researchers studied the responses of PBMCs from individuals of different age groups (young, middle - aged, and elderly) to SARS - CoV - 2. The main findings include: - **Impaired activation of DCs and monocytes**: As people age, the activation ability of DCs and monocytes to SARS - CoV - 2 decreases, especially in plasmacytoid DCs (pDCs), where this decrease is more obvious. - **Reduced secretion of antiviral cytokines**: The secretion of IL - 29 (a protective antiviral cytokine) in the elderly is significantly reduced. - **Increased inflammatory mediators**: Inflammatory mediators associated with severe COVID - 19 (such as CXCL - 8 and TREM - 1) are significantly increased in the elderly. - **Gene expression changes**: Pathways related to host defense show a decline with age, while inflammatory pathways increase. - **Impaired CD8 T - cell response**: The induction of CD8 T - cells in the elderly is impaired, but the baseline activation level is higher, which is consistent with enhanced baseline inflammation. ### Conclusion The research results show that as people age, the protective antiviral immune response decreases, while the harmful inflammatory response increases, indicating that the dysregulated innate immune response plays an important role in the increased susceptibility of the elderly to COVID - 19. In addition, this dysregulation of the immune response has also been shown in middle - aged people, indicating that this process begins at an earlier stage. ### Keywords SARS - CoV - 2; Innate immunity; DCs; Monocytes; IL - 29; RNA - seq; Aging; CD8 T - cells Through these findings, researchers hope to be able to provide a theoretical basis for the development of new treatment strategies to improve the resistance of the elderly to respiratory virus infections.

Changes in the innate immune response to SARS-CoV-2 with advancing age in humans

Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?

Distinct SARS-CoV-2 specific NLRP3 and IL-1β responses in T cells of aging patients during acute COVID-19 infection

Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19

SARS-CoV-2, COVID-19 and the aging immune system

Aging, inflammaging and immunosenescence as risk factors of severe COVID-19

Molecular and cellular immune features of aged patients with severe COVID-19 pneumonia

Patho-Physiology of Aging and Immune-Senescence: Possible Correlates With Comorbidity and Mortality in Middle-Aged and Old COVID-19 Patients

SARS-CoV-2 infection represents a high risk for the elderly: analysis of pathogenesis

Aging is associated with an insufficient early inflammatory response of lung endothelial cells in SARS-CoV-2 infection

Identifying Age-Related Risk Factors in COVID-19 Independent of Disease Severity

Host-Microbe Multiomic Profiling Reveals Age-Dependent COVID-19 Immunopathology

Delayed viral clearance and altered inflammatory responses resulted in increased severity of SARS-CoV-2 infection in aged mice.

COVID‐19 is an emergent disease of aging

The immunobiology of SARS-CoV-2 infection and vaccine responses: potential influences of cross-reactive memory responses and aging on efficacy and off-target effects

The aging transcriptome and cellular landscape of the human lung in relation to SARS-CoV-2

Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

Genomic Analysis Reveals Age-Dependent Innate Immune Responses to Severe Acute Respiratory Syndrome Coronavirus

Immunological characteristics in elderly COVID-19 patients: a post-COVID era analysis

A human circulating immune cell landscape in aging and COVID-19

Age Related Differences in Monocyte Subsets and Cytokine Pattern during Acute COVID-19-A Prospective Observational Longitudinal Study